ELEVATE 2: A multicenter study of rodatristat ethyl in patients with WHO Group 1 pulmonary arterial hypertension (PAH)
H. Lazarus (Cary, NC, United States of America), J. Denning (Cary, NC, United States of America), W. Kamau-Kelley (Cary, NC, United States of America), S. Wring (Cary, NC, United States of America), M. Palacios (Cary, NC, United States of America), M. Humbert (Paris, France)
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Session: Therapy of pulmonary hypertension
Session type: E-poster
Number: 1919
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Lazarus (Cary, NC, United States of America), J. Denning (Cary, NC, United States of America), W. Kamau-Kelley (Cary, NC, United States of America), S. Wring (Cary, NC, United States of America), M. Palacios (Cary, NC, United States of America), M. Humbert (Paris, France). ELEVATE 2: A multicenter study of rodatristat ethyl in patients with WHO Group 1 pulmonary arterial hypertension (PAH). 1919
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: